MedTrace Logo

PEL-1235_REN-0176-I (Pelicon)

NCT01904045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2018-09-13

No results posted yet for this study

Summary

Aim of this study is to investigate whether in patients following kidney transplantation (\>6 months after transplantation), the intra-patient variability of levels of tacrolimus is comparable after administration of tacrolimus twice daily (Prograf) to tacrolimus once daily (Advagraf), with each regimen for 3 months.

Conditions

  • Immunosuppression After Kidney Transplantation

Interventions

OTHER

tacrolimus Advagraf

intake of Advagraf once daily for 3 months

OTHER

tacrolimus Prograf

intake of Prograf twice daily for 3 months

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2018-01-31
Completion
2018-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01904045 on ClinicalTrials.gov